Sterilizing filtration of liquids

PDA Journal of Pharmaceutical Science and Technology

Volumn 62, Issue SUPPL. 5, 2008, Pages 1-60

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ADSORPTION; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; ARTIFICIAL MEMBRANE; ASEPSIS; AUTOCLAVE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOCOMPATIBILITY; CORRELATION ANALYSIS; CULTURE MEDIUM; DIFFUSION; DISINFECTION; DISPOSABLE EQUIPMENT; DRUG INDUSTRY; EFFLUENT; EQUIPMENT DESIGN; FILTER; FILTRATION; FLOW RATE; GAMMA RADIATION; HYDROPHILICITY; HYDROPHOBICITY; INFECTION PREVENTION; INFECTION RISK; INFRARED SPECTROSCOPY; INSTRUMENT STERILIZATION; LEACHING; LIQUID; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATERIALS HANDLING; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MICROORGANISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PARTICLE SIZE; PEER REVIEW; PH; PHYSICAL CHEMISTRY; POLICY; POROSITY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RADIATION EXPOSURE; RELIABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; SAMPLING; STANDARDIZATION; SURFACE TENSION; TEMPERATURE; VALIDATION PROCESS; VALIDATION STUDY; WATER VAPOR; WETTABILITY;

EID: 59349084481     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Carter, J. R.; Levy, R. V. Microbial Retention Testing in the Validation of Sterilizing 1.Filtration. In Filtration in the Biopharmaceutical Industry; Meltzer, T. H., Jornitz, M. W, Eds.; Marcel Dekker: New York, 1998.
2. Akers, J. A. Microbial Considerations in the Selection and Validation of Filter Sterilization. In Filtration and Purification in the Biopharmaceutical Industry; Meltzer, T H., Jornitz, M. W, Eds.; Informa Healthcare: New York, 2008.
3. Mittelman, M. W.; Jornitz M.; Meltzer, T. Bacterial Cell Size and Surface Charge Characteristics Relevant to Filter Validation Studies. PDA J. Pharm. Sci. Technol. 1998, 52, 37-42.
4. Sundaram, S.; Auriemma, M.; Howard G.H., Jr.; Brandwein, H.; Leo, F. Application of Membrane Filtration for Removal of Diminutive Bioburden Organisms in Pharmaceutical Products and Processes. PDA J. Pharm. Sci. Technol. 1999, 53, 186-201.
5. Bowman, F. W.; Holdowsky, S. Production and Control of a Stable Penicillinase. Antibiot. Chemother. 1960, 10, 508.
6. Committee D19, F838-05 Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration. American Society for Testing and Materials International (ASTM): 2005.
7. Aseptic Processing of Health Care Products - Part 2: Filtration, 3 Terms and Definitions 13408-2:2003 (E). ISO: 2003.
8. Tanny, G. B.; Strong, D. K.; Presswood, W. G.; Meltzer, T. H. Adsorptive Retention of Pseudomonas diminuta by Membrane Filters. J. Parent. Drug Assoc. 1979, 33, 40-51.
9. Howard, G.; Duberstein, R. A Case of Penetration of 0.2μm Rated Membrane Filters by Bacteria. J. Parent. Drug Assoc. 1980, 34, 93-102.
10. Meeker, J.T.; Hickey, E.W.; Martin, J.M.; Howard, Jr., G. Technical Note: A Quantitative Method for Challenging 0.1 mm Rated Filters with A. laidlawii. Biopharm Intl. 1992, (March), 30.
11. Roche, K.L.; Levy, R. V. Methods Used to Validate Microporous Membranes for the Removal of Mycoplasma. BioPharm Intl. 1993, (May), 22-33.
12. 2 Challenge. Pharm. Technol. 1993, 7, 28-35.
13. Carter, J. Evaluation of Recovery Filters for Use in Bacterial Retention Testing of Sterilizing-Grade Filters. PDA J. Pharm. Sci. Technol. 1996, 50, 147-163.
14. The Rules Governing Medicinal products in the European Union, Volume 4. Medicinal Products for Human and Veterinary Use: Good Manufacturing Practices. Annex 1 Manufacture of Sterile Medicinal Products. 2003.
15. Meltzer, T. H. Some Observations Concerning Filter Validations. Proceedings of the PDA Second International Congress, Basel, Switzerland, 1993.
16. Current Good Manufacturing Practice for Finished Pharmaceuticals. Code of Federal Regulations, Part 211, Title 21, 2007.
17. Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs. Code of Federal Regulations. Part 210, Title 21, 2006.
18. <88> Biological Reactivity Tests, In Vivo. USP 31/NF 26. The United States Pharmacopeia Convention: Rockville, MD, 2007.
19. <87> Biological Reactivity Tests, In Vitro. USP 31-NF 26. The United States Pharmacopeia Convention: Rockville, MD, 2007.
20. Current Good Manufacturing Practice for Substances Prohibited from Use in Human Food. Code of Federal Regulations, Part 189, Title 21, 2007.
21. Current Good Manufacturing Practice Requirements for Specific Cosmetic Products. Code of Federal Regulations, Part 700, Title 21, 2007.
22. Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products, Section 6.4, Tallow Derivatives (EMEA/410/01 Revision 2). European Medicines Agency: 2004.
23. Stone, T.; Goel, V.; Leszczak, J.; Chrai, S. Model Stream Approach: Defining Worst Case Conditions. Pharm. Technol., 1996, 20(22), 34-51.
24. Reif, O. W. Extractables and Compatibilities of Filters. In Filtration in the Biopharmaceutical Industry; Meltzer, T. H., Jornitz, M. W., Eds.; Marcel Dekker: New York, 1998.
25. Clarke, M. E.; Zahka, J. Understanding Membrane Plugging Mechanisms, Microelectronics Application Note MAL 116. Mykrolis, 2000, White Paper. 1-22.
26. Fennington, Jr. G. J.; Howard, Jr. G. Preparation and Evaluation of Bacterial Stocks for Filter Validation. PDA J. Pharm. Sci. Technol. 1997, 51, 153-155.
27. Leahy, T. J.; Sullivan, M. Validation of Bacterial Retention Capabilities of Membrane Filters. Pharm. Technol. 1978, 2(11), 64-75.
28. Meltzer, T. H. Filtration in the Pharmaceutical Industry; Meltzer, T. H., Jornitz, M. W., Eds.; Marcel Dekker: New York, 1987.
29. Sundaram S.; Brantley, J.D.; Howard, Jr. G.; Brandwein, H. Considerations on Using 'Bubble Point' Type Tests as Filter Integrity Tests, Part I. Pharm. Technol. 2000, 24(9), 90-115.
30. Sundaram S.; Brantley, J.D.; Howard, Jr. G.; Brandwein, H. Part II: Effect of Filter Area on 'Bubble Point' Measurements and Implications for the Use of 'Bubble Point' Type Tests as Correlated Tests. Pharm. Technol. 2000, 24(10), 108-136.
31. Pall, D. B.; Kirnbauer, E. A. Bacteria Removal Prediction in Membrane Filters. Presented at 52nd Colloid and Surface Science Symposium, University of Tennessee, Knoxville, TN, June 1978.
32. Reti, A. R. An Assessment of Test Criteria for Evaluation the Performance and Integrity of Sterilizing Filters. Bull. Parent. Drug Assoc. 1977, 31, 187-193.
33. Jornitz, M. W.; Brose D. J.; Meltzer, T. H. Experimental Evaluation of Diffusive Airflow Integrity Testing. PDA J. Pharm. Sci. Technol. 1998, 5, 46-49.
34. Guidance for Industry Sterile Drug Products Produced by Aseptic Processing-Current Good Manufacturing Practice; Guideline on Sterile Drug Products Produced by Aseptic Processing. U.S. Food and Drug Administration: 2004.
35. Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 1, Manufacture of Sterile Medicinal Products (Vol. 4) European Union: 2003.
36. Jornitz, M. W., Trotter, A. M., Meltzer, T. H. Integrity Testing. In Filtration in the Biopharmaceutical Industry; Meltzer, T. H., Jornitz, M. W., Eds.; Marcel Dekker: New York, 1998.
37. Trotter, A. M.; Meltzer, T. H., et al. Investigation of a Filter Structure by Microbial Retention Studies: A Synthesis and Elaboration of Prior Findings. PDA J. Pharm. Sci. Technol. 2001, 55, 127-133.
38. Agalloco, J. P. Steam Sterilization-In-Place Technology. PDA J. Pharm. Sci. Technol. 1990, 44, 253-256.
39. Technical Report No. 1 (Revised 2007): Moist Heat Sterilization Processes: Cycle Design, Development, Qualification and Ongoing Control; Parenteral Drug Association: Bethesda, MD, 2007.
40. Myers, T.; Chrai, S. Steam-In-Place Sterilization of Cartridge Filters In-Line with a Receiving Tank. J. Parent. Sci. Tech. 1982, 36, 108-112.
41. Steere, W.; Meltzer, T. H. Operational Considerations in the Steam Sterilization of Cartridge Filters. Pharm. Technol. 1993, 9, 98-110.
42. Sterilization of Health Care Products - Radiation, Part 1: Requirements for Development, Validation and Routine Control of a Sterilization Process for Medical Devices, 11137-1:2006. ANSI/AAMI/ ISO: 2006.
43. Sterilization of Health Care Products - Radiation - Part 2: Establishing the Sterilization Dose, 11137-2:2006. ANSI/AAMI/ISO: 2006.
44. Sterilization of Health Care Products - Radiation - Part 3: Guidance on Dosimetric Aspects, 11137-3:2006. ANSI/AAMI/ISO: 2006.
45. Note for Guidance on Development Pharmaceutics (CPMP (CPMP/QWP/ 155/96). European Medicines Agency: 1998.
46. Decision Tree for Selection of Sterilisation Methods (CPMP/QWP/ 054/98 Corr.), Annex to Note for Guidance on Development Pharmaceutics (CPMP/QWP/155/96). European Medicines Agency: 2000.
47. ANSI. Sterilization of Health Care Products - Radiation Sterilization - Substantiation of a Selected Sterilization Dose - Method VDmax, AMI TIR33: 2005 2.
48. ANSI/AAMI/ISO. Medical devices - Validation and Routine Control of Ethylene Oxide Sterilization, 11135:1994.
49. BPSA Guidelines and Standards Committee. BioProcess Systems Alliance Component Quality Test Matrices. BioProcess Intl., 2007, 5(4), 52-57.
50. Hofmann, F. Integrity Testing of Microfiltration Membranes, J. Parent. Sci. Tech., 1984, 148-159.
51. Emory, S. F. Principles of Integrity-Testing Hydrophilic Microporous Membrane Filters, Part I, II. Pharm. Technol. 1989, 9, 68-77; 10, 36-46.
52. Jornitz, M. W., et al. Filter Integrity Testing in Liquid Applications, Revisited, Part 1. Pharm. Technol. 2001, October, 34-50.
53. Jornitz, M. W., et al. Filter Integrity Testing in Liquid Applications, Revisited, Part 2. Pharm. Technol. 2001, October, 24-35.